Adam S. Grossman
CIK: 0001542517
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ADMA BIOLOGICS, INC.
Discretionary Trading P&L
Holdings
Transaction History (49 total)
- Mar 16, 2026ADMA
ADMA BIOLOGICS, INC.
Exercise(M)Direct15K shares at avg. $5.40$81K - Mar 16, 2026ADMA
ADMA BIOLOGICS, INC.
Sale(S)Direct6K shares at avg. $15.16$91K - Mar 16, 2026ADMA
ADMA BIOLOGICS, INC.
Sale(S)Direct15K shares at avg. $15.16$227K - Mar 7, 2026ADMA
ADMA BIOLOGICS, INC.
Tax Payment(F)Direct29.5K shares at avg. $15.39$454K - Mar 6, 2026ADMA
ADMA BIOLOGICS, INC.
Tax Payment(F)Direct56.4K shares at avg. $15.39$869K - Feb 26, 2026ADMA
ADMA BIOLOGICS, INC.
Tax Payment(F)Direct54.9K shares at avg. $15.18$833K - Feb 19, 2026ADMA
ADMA BIOLOGICS, INC.
Tax Payment(F)Direct24.8K shares at avg. $16.32$405K - Feb 17, 2026ADMA
ADMA BIOLOGICS, INC.
Sale(S)Direct6K shares at avg. $16.08$96K - Feb 17, 2026ADMA
ADMA BIOLOGICS, INC.
Exercise(M)Direct15K shares at avg. $5.40$81K - Feb 17, 2026ADMA
ADMA BIOLOGICS, INC.
Sale(S)Direct15K shares at avg. $16.08$241K - Feb 9, 2026ADMA
ADMA BIOLOGICS, INC.
Award(A)Direct282.5K shares- - Dec 15, 2025ADMA
ADMA BIOLOGICS, INC.
Exercise(M)Direct15K shares at avg. $5.40$81K - Dec 15, 2025ADMA
ADMA BIOLOGICS, INC.
Sale(S)Direct6K shares at avg. $19.79$119K - Dec 15, 2025ADMA
ADMA BIOLOGICS, INC.
Sale(S)Direct15K shares at avg. $19.79$297K - Nov 19, 2025ADMA
ADMA BIOLOGICS, INC.
Exercise(M)Direct15K shares at avg. $5.40$81K - Nov 19, 2025ADMA
ADMA BIOLOGICS, INC.
Sale(S)Direct6K shares at avg. $16.00$96K - Nov 19, 2025ADMA
ADMA BIOLOGICS, INC.
Sale(S)Direct15K shares at avg. $16.00$240K - Oct 24, 2025ADMA
ADMA BIOLOGICS, INC.
Sale(S)Direct6K shares at avg. $16.00$96K - Oct 24, 2025ADMA
ADMA BIOLOGICS, INC.
Exercise(M)Direct15K shares at avg. $5.40$81K - Oct 24, 2025ADMA
ADMA BIOLOGICS, INC.
Sale(S)Direct15K shares at avg. $16.00$240K - Sep 15, 2025ADMA
ADMA BIOLOGICS, INC.
Sale(S)Direct15K shares at avg. $16.13$242K - Sep 15, 2025ADMA
ADMA BIOLOGICS, INC.
Sale(S)Direct6K shares at avg. $16.13$97K - Sep 15, 2025ADMA
ADMA BIOLOGICS, INC.
Exercise(M)Direct15K shares at avg. $5.40$81K - Aug 15, 2025ADMA
ADMA BIOLOGICS, INC.
Sale(S)Direct6K shares at avg. $16.88$101K - Aug 15, 2025ADMA
ADMA BIOLOGICS, INC.
Sale(S)Direct15K shares at avg. $16.88$253K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 16, 2026 | ADMA ADMA BIOLOGICS, INC. | Exercise(M) | 15,000 | $5.40 | $81,000 | Direct |
| Mar 16, 2026 | ADMA ADMA BIOLOGICS, INC. | Sale(S) | 6,000 | $15.16 | $90,960 | Direct |
| Mar 16, 2026 | ADMA ADMA BIOLOGICS, INC. | Sale(S) | 15,000 | $15.16 | $227,400 | Direct |
| Mar 7, 2026 | ADMA ADMA BIOLOGICS, INC. | Tax Payment(F) | 29,513 | $15.39 | $454,205 | Direct |
| Mar 6, 2026 | ADMA ADMA BIOLOGICS, INC. | Tax Payment(F) | 56,438 | $15.39 | $868,581 | Direct |
| Feb 26, 2026 | ADMA ADMA BIOLOGICS, INC. | Tax Payment(F) | 54,858 | $15.18 | $832,744 | Direct |
| Feb 19, 2026 | ADMA ADMA BIOLOGICS, INC. | Tax Payment(F) | 24,793 | $16.32 | $404,622 | Direct |
| Feb 17, 2026 | ADMA ADMA BIOLOGICS, INC. | Sale(S) | 6,000 | $16.08 | $96,480 | Direct |
| Feb 17, 2026 | ADMA ADMA BIOLOGICS, INC. | Exercise(M) | 15,000 | $5.40 | $81,000 | Direct |
| Feb 17, 2026 | ADMA ADMA BIOLOGICS, INC. | Sale(S) | 15,000 | $16.08 | $241,200 | Direct |
| Feb 9, 2026 | ADMA ADMA BIOLOGICS, INC. | Award(A) | 282,529 | - | $0 | Direct |
| Dec 15, 2025 | ADMA ADMA BIOLOGICS, INC. | Exercise(M) | 15,000 | $5.40 | $81,000 | Direct |
| Dec 15, 2025 | ADMA ADMA BIOLOGICS, INC. | Sale(S) | 6,000 | $19.79 | $118,740 | Direct |
| Dec 15, 2025 | ADMA ADMA BIOLOGICS, INC. | Sale(S) | 15,000 | $19.79 | $296,850 | Direct |
| Nov 19, 2025 | ADMA ADMA BIOLOGICS, INC. | Exercise(M) | 15,000 | $5.40 | $81,000 | Direct |
| Nov 19, 2025 | ADMA ADMA BIOLOGICS, INC. | Sale(S) | 6,000 | $16.00 | $96,000 | Direct |
| Nov 19, 2025 | ADMA ADMA BIOLOGICS, INC. | Sale(S) | 15,000 | $16.00 | $240,000 | Direct |
| Oct 24, 2025 | ADMA ADMA BIOLOGICS, INC. | Sale(S) | 6,000 | $16.00 | $96,000 | Direct |
| Oct 24, 2025 | ADMA ADMA BIOLOGICS, INC. | Exercise(M) | 15,000 | $5.40 | $81,000 | Direct |
| Oct 24, 2025 | ADMA ADMA BIOLOGICS, INC. | Sale(S) | 15,000 | $16.00 | $240,000 | Direct |
| Sep 15, 2025 | ADMA ADMA BIOLOGICS, INC. | Sale(S) | 15,000 | $16.13 | $241,950 | Direct |
| Sep 15, 2025 | ADMA ADMA BIOLOGICS, INC. | Sale(S) | 6,000 | $16.13 | $96,780 | Direct |
| Sep 15, 2025 | ADMA ADMA BIOLOGICS, INC. | Exercise(M) | 15,000 | $5.40 | $81,000 | Direct |
| Aug 15, 2025 | ADMA ADMA BIOLOGICS, INC. | Sale(S) | 6,000 | $16.88 | $101,280 | Direct |
| Aug 15, 2025 | ADMA ADMA BIOLOGICS, INC. | Sale(S) | 15,000 | $16.88 | $253,200 | Direct |
1-25 of 49 transactions
About Grossman Adam S
Grossman Adam S (SEC CIK 0001542517) files insider reports with the SEC as President and CEO of ADMA BIOLOGICS, INC. (ADMA).
Signal8 holds 22 ownership filings by Grossman Adam S, all Form 4s, filed between Oct 2, 2024 and Mar 17, 2026. Those filings report 49 transactions, from Sep 30, 2024 to Mar 16, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Grossman Adam S's filings is in RAMSEY, NJ.
Recent filings by Grossman Adam S
- Mar 16, 2026: Option exercise of ADMA shares (Form 4, code M).
- Mar 16, 2026: Open-market sales of ADMA shares (2 lines, Form 4, code S).
- Mar 7, 2026: Tax withholding of ADMA shares (Form 4, code F).
- Mar 6, 2026: Tax withholding of ADMA shares (Form 4, code F).
- Feb 26, 2026: Tax withholding of ADMA shares (Form 4, code F).
Other insiders filing for ADMA BIOLOGICS, INC. (ADMA)
- Kestenberg-Messina Kaitlin M., COO and SVP, Compliance
- Kohler Terry, CFO and Treasurer
- Grossman Jerrold B, Director
- Guiheen Lawrence P., Director
- ELMS STEVE, Director
- Tade Brad L., CFO and Treasurer